Navigation Links
Bio-Pharma Industry Improves Patient Outcomes Through Continuing Medical Education (CME)
Date:10/20/2008

CHAPEL HILL, N.C., Oct. 20 /PRNewswire/ -- With limited information on actual return on investment for expenditures toward support of Continuing Medical Education activities, pharmaceutical, biotechnology and medical device industry executives are anxious to understand the value of CME support and strategies for ensuring investments provide appropriate impact on healthcare practitioner behaviors and patient outcomes. In the recently published report by benchmarking firm, Best Practices, LLC, reviewing the CME support functions, benchmark respondents found significant opportunity for maximizing resources through centralization and innovative use of E-CME. Data from this study, "Educating the Market: Creating Value through Support of Continuing Medical Education," identified several key practices and metrics that can enable organizations to identify performance gaps and areas for improvement to better manage their CME support functions.

To view the study abstract or complimentary summary of the full report "Educating the Market: Creating Value through Support of Continuing Medical Education," click on the following link http://www3.best-in-class.com/rr971.htm .

In a benchmarking study that included such influential companies as AstraZeneca, Bristol-Myers Squibb, Genentech, Johnson & Johnson, Merck, Pfizer, Roche, Sanofi-Aventis and Wyeth, many key questions were covered, including:

-- What is the current landscape of continuing medical education (CME) in

North America and Europe?

-- What structural forms are used to deploy CME, optimize budgets & best

deliver content?

-- How rapidly is E-CME advancing?

-- What CME delivery channels are preferred?

-- What are the current trends and future directions of CME?

Among the key topics gathered in this report are:

-- Geographic delivery of CME

-- Structural manage
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Signs Exclusive Management Operating Agreement with Xian Qinba Xintong Medical Ltd.; HFGB to Retain Up to 70% of Qinbas Total Profit
2. Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xian Qinba Xintong Medical Ltd.
3. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
4. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
5. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
6. Best Practice Database Supports Bio-Pharma Product Launch
7. Huifeng Bio-Pharmaceutical (HFGB) to Release Second Quarter 2008 Earnings Results on August 15, 2008
8. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status
9. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
10. Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister
11. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/19/2014)... Piscataway, NJ (PRWEB) August 20, 2014 ... engineering and regenerative medicine is an inadequate vascular ... engineered constructs and decellularized tissues is critical for ... Researchers have attempted to mitigate deficiencies in vascularization ... including adding scaffold bioactivity, optimizing scaffold design and ...
(Date:8/19/2014)... Calif. (PRWEB) August 19, 2014 ... campaign to raise $200,000 to fund a corporate ... device. , This development is a critical ... model of care to the implementation of personalized ... method of practicing medicine. , Indiegogo contributions will ...
(Date:8/19/2014)... 19, 2014 Research and ... the "Spectroscopy Equipment and Accessories - ... their offering. This report ... and Accessories in US$ Thousands by the ... Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared (NIR) ...
Breaking Biology Technology:Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2
... VIENNA, Austria, November 28 f-star, an antibody,engineering company ... Modular Antibody Technology, today announced that it,has raised EUR ... of its Series,A financing round, originally co-led by Aescap ... raised in the Series A round,increases to EUR 9.0 ...
... 1-41 has significant ... and anti-amnesic benefits, GENEVA, Nov. 28 /PRNewswire-FirstCall/ - ... announce promising developments with,ANAVEX 1-41, the company,s lead drug ... 1-41 prevented oxidative stress,which damages and destroys cells and ...
... November 28 The results of a,study on ... desensitisation product, which is due to receive German ... VO52.06, which was carried out on 280,patients in ... the main evaluation criterion by,demonstrating a statistically significant ...
Cached Biology Technology:Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 3Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study 2
(Date:8/19/2014)... To improve students, chances of completing introductory ... of Houston (UH) implemented a comprehensive student success ... for failure. , Through a grant from ... Department of Biology and Biochemistry embarked on a ... Biology" for non-majors and "Introductory Biology" for science ...
(Date:8/19/2014)... It,s not a lemur. It,s not an African Bush Baby ... tiny, adorable and downright "cool" primate from Southeast Asia. , ... with," said Rafe Brown, curator-in-charge at the University of Kansas, ... extremely cute, furry body; a long tail with a furry ... tips that look a bit like the disks on the ...
(Date:8/19/2014)... a biomarker strongly associated with basal-like breast cancer, ... many types of chemotherapy. The biomarker, a protein ... therapeutics designed to treat this often deadly cancer. ... The Cancer Genome Atlas, molecular biologists Curt M. ... and bioinformatics techniques to detect patterns of gene ...
Breaking Biology News(10 mins):University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3
... The decline of large predators and other "apex consumers" at ... the planet. The finding is reported by an international ... of the journal Science . The study looked ... and marine ecosystems and concluded "the loss of apex consumers ...
... 14, 2011 Two studies published in the current ... that consuming in-shell pistachios is a weight-wise approach to ... curb consumption and decrease calorie intake. ... pistachios ate 41-percent fewer calories compared to those who ...
... East Coast may be at risk to higher sea levels ... years, according to a new study by NOAA. The ... surges along the East Coast during the 2009-2010 El Nio ... NOAA,s Center for Operational Oceanographic Products and Services, examined water ...
Cached Biology News:Loss of large predators caused widespread disruption of ecosystems 2Loss of large predators caused widespread disruption of ecosystems 3In-shell pistachios: The original 'slow food?' 2In-shell pistachios: The original 'slow food?' 3Strong El Niño could bring increased sea levels, storm surges to US East Coast 2
BD BaculoGold Max-XP Insect Cell Medium 1 Liter...
Newborn Bovine Serum Heat-Inactivated...
Performance, mycoplasma, virus, and endotoxin tested...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Biology Products: